| 100158-5 | Microalbumin collected for unspecified duration (Urine) |
| 100359-9 | Gliadin 33 mer peptide (Stool, immunoassay) |
| 100372-2 | Abiraterone |
| 100424-1 | 8(9)-Cholestenol |
| 100425-8 | DiHydro T-Mas |
| 100426-6 | Squalene |
| 100427-4 | Stigmasterol |
| 100435-7 | Glial fibrillary acidic protein (immunoassay) |
| 100436-5 | Ubiquitin carboxyl-terminal hydrolase-L1 (immunoassay) |
| 100437-3 | Norsufentanil (Urine, confirmatory method) |
| 100712-9 | Brexpiprazole |
| 100713-7 | Cariprazine |
| 100714-5 | Guanfacine |
| 100715-2 | Prothipendyl |
| 100716-0 | Prostate specific Ag (Dbs) |
| 100733-5 | Cholesterol in LDL (calculation --corrected for cholesterol.in lipoprotein (little a)) |
| 100744-2 | Alpha-1-acid glycoprotein (electrophoresis) |
| 100788-9 | Stemphylium botryosum IgG4 Ab |
| 100789-7 | Rhizopus nigricans IgG4 Ab |
| 100790-5 | Lepidoglyphus destructor IgG Ab |
| 100791-3 | Hamster epithelium IgG Ab |
| 100793-9 | Testosterone (Body Fluid) |
| 100795-4 | S100 calcium binding protein B (Body Fluid) |
| 100796-2 | Thyroglobulin (Body Fluid) |
| 100797-0 | Testosterone Free --1st specimen post XXX challenge |
| 100798-8 | Testosterone Free --2nd specimen post XXX challenge |
| 100799-6 | 21-Deoxycortisol --1st specimen post XXX challenge |
| 100800-2 | 21-Deoxycortisol --2nd specimen post XXX challenge |
| 100801-0 | 21-Deoxycortisol --3rd specimen post XXX challenge |
| 100802-8 | 21-Deoxycortisol --4th specimen post XXX challenge |
| 100803-6 | 21-Deoxycortisol --5th specimen post XXX challenge |
| 100816-8 | Glucagon --6th specimen post XXX challenge |
| 100817-6 | Glucagon --7th specimen post XXX challenge |
| 100818-4 | Renin --1st specimen post XXX challenge |
| 100819-2 | Renin --2nd specimen post XXX challenge |
| 100820-0 | Renin --3rd specimen post XXX challenge |
| 100829-1 | Renin --4th specimen post XXX challenge |
| 100837-4 | Insulin-like growth factor-I --9th specimen post XXX challenge |
| 100838-2 | Testosterone --9th specimen post XXX challenge |
| 100914-1 | Protein.abnormal band (electrophoresis) |
| 100976-0 | Eosinophil derived neurotoxin |
| 100996-8 | Neurofilament light chain (CSF) |
| 101122-0 | Mephobarbital (Blood, confirmatory method) |
| 101145-1 | Ustekinumab (immunoassay --trough) |
| 101153-5 | Chemokine (C-C motif) ligand 14 (Urine, immunoassay) |
| 101154-3 | Calprotectin |
| 101163-4 | Brorphine (Urine, confirmatory method) |
| 101166-7 | Metonitazene (Urine, confirmatory method) |
| 101169-1 | 2-methyl AP-237 (Urine, confirmatory method) |
| 101170-9 | Soluble urokinase plasminogen activator receptor |
| 101174-1 | 17-Hydroxyprogesterone (oral fluid) (Saliva) |
| 101181-6 | MDMB-4en-PINACA (Urine, confirmatory method) |
| 101184-0 | 4F-MDMB-BINACA (Urine, confirmatory method) |
| 101187-3 | ADB-BUTINACA (Urine, confirmatory method) |
| 101190-7 | 5F-MDMB-PICA (Urine, confirmatory method) |
| 101198-0 | Albumin (nephelometry) |
| 101249-1 | Delta-8-tetrahydrocannabinol (Urine, lc/ms/ms) |
| 101252-5 | Urea in Dialysis fluid |
| 101281-4 | Neurofilament light chain (immunoassay) |
| 101309-3 | Glucose --2 hours post dose arginine |
| 101311-9 | 17-Hydroxyprogesterone --30 minutes post dose corticotropin |
| 101312-7 | 17-Hydroxyprogesterone --1 hour post dose corticotropin |
| 101317-6 | 17-Hydroxypregnenolone --30 minutes post dose corticotropin |
| 101318-4 | 17-Hydroxypregnenolone --1 hour post dose corticotropin |
| 101411-7 | Dupilumab (lc/ms/ms --trough) |
| 101412-5 | Dolutegravir (lc/ms/ms --trough) |
| 101413-3 | Bictegravir (lc/ms/ms --trough) |
| 101443-0 | Soluble urokinase plasminogen activator receptor |
| 101543-7 | Tumor necrosis factor ligand superfamily member 10, Plasma or Blood |
| 101589-0 | Histoplasma capsulatum+Blastomyces dermatitidis Ag (immunoassay) |
| 101648-4 | 14-3-3 Ag (CSF, immunoassay) |
| 101649-2 | Tau protein (CSF, immunoassay) |
| 101724-3 | Certolizumab Ab (spr) |
| 101793-8 | Tianeptine (Urine, confirmatory method) |
| 101808-4 | Xylazine (Urine, confirmatory method) |
| 101813-4 | 2,6-dimethylaniline (Urine, confirmatory method) |
| 101829-0 | Tetrazepam |
| 101830-8 | Medazepam |
| 101860-5 | 4F-MDMB-BUTICA (Urine, confirmatory method) |
| 101911-6 | Troponin T. cardiac in 2 hour 5th generation Serum or Plasma |
| 101915-7 | Troponin T.cardiac in 6 hour Serum or Plasma |
| 101924-9 | Transforming growth factor beta 1 (Urine, immunoassay) |
| 101925-6 | Epidermal growth factor (Urine, immunoassay) |
| 101926-4 | Connective tissue growth factor (immunoassay) |
| 101927-2 | Calbindin D28K (Urine, immunoassay) |
| 101976-9 | Voltage-gated calcium channel P/Q type binding Ab (immunoassay) |
| 102018-9 | Glucose --1 hour post dose glucagon |
| 102019-7 | Glucose --1.5 hours post dose glucagon |
| 102020-5 | Glucose --2 hours post dose glucagon |
| 102021-3 | Glucose --2.5 hours post dose glucagon |
| 102022-1 | Glucose --3 hours post dose glucagon |
| 102023-9 | Cortisol --30 minutes post dose glucagon |
| 102025-4 | Cortisol --1.5 hours post dose glucagon |
| 102026-2 | Cortisol --2 hours post dose glucagon |
| 102027-0 | Cortisol --2.5 hours post dose glucagon |
| 102028-8 | Cortisol --3 hours post dose glucagon |
| 102029-6 | Somatotropin --Fasting post dose insulin IV |
| 102032-0 | Glucose --2 hours post dose insulin IV |
| 102051-0 | 1-deoxysphinganine (lc/ms/ms) |
| 102052-8 | 1-Deoxysphingosine (lc/ms/ms) |